Daiichi Sankyo Brasil Farmacêutica Ltda. (Daiichi Sankyo Brasil Farmacêutica Ltda.)

概览

关联

1

项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的临床试验

NCT02616068 / Completed临床3期

A Phase III, Randomized, Double Blind, Non-inferiority, Comparative Study of the New Transdermal Patch Dosage Form Containing Loxoprofen Sodium (100 mg) and Loxonin® (60 mg Tablet) for the Treatment of Acute Traumatic Injuries

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - Daiichi-Sankyo) for the treatment of acute traumatic injuries.

开始日期2015-10-01

申办/合作机构

Daiichi Sankyo Brasil Farmacêutica Ltda.

[+2]

100 项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的临床结果

登录后查看更多信息

0 项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的专利（医药）

登录后查看更多信息

1

项与 Daiichi Sankyo Brasil Farmacêutica Ltda. 相关的文献（医药）

Arquivos Brasileiros de Cardiologia

Study Design of a Brazilian Observational Study of Edoxaban in Patients with Atrial Fibrillation (EdoBRA)